These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12115111)

  • 1. Thrombocytopenia secondary to linezolid administration: what is the risk?
    Orrick JJ; Johns T; Janelle J; Ramphal R
    Clin Infect Dis; 2002 Aug; 35(3):348-9. PubMed ID: 12115111
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombocytopenia associated with linezolid therapy.
    Attassi K; Hershberger E; Alam R; Zervos MJ
    Clin Infect Dis; 2002 Mar; 34(5):695-8. PubMed ID: 11803505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic effects of linezolid versus vancomycin.
    Young LS
    Clin Infect Dis; 2004 Apr; 38(8):1065-6. PubMed ID: 15095208
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombocytopenia and anemia associated with linezolid in patients with kidney failure.
    Mateu de Antonio J; Grau S; Morales-Molina JA; Marín-Casino M
    Clin Infect Dis; 2006 May; 42(10):1500; author reply 1501. PubMed ID: 16619168
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal function as a predictor of linezolid-induced thrombocytopenia.
    Matsumoto K; Takeda Y; Takeshita A; Fukunaga N; Shigemi A; Yaji K; Shimodozono Y; Yamada K; Ikawa K; Morikawa N
    Int J Antimicrob Agents; 2009 Jan; 33(1):98-9. PubMed ID: 18790615
    [No Abstract]   [Full Text] [Related]  

  • 6. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
    Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR
    Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid-associated thrombocytopenia.
    Lam S
    Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
    Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological safety of long-term therapy with linezolid.
    Garazzino S; De Rosa FG; Bargiacchi O; Audagnotto S; Maiello A; Di Perri G
    Int J Antimicrob Agents; 2007 Apr; 29(4):480-3. PubMed ID: 17317112
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case report: severe thrombocytopenia].
    Sakka SG; Schürmann A; Knüttgen D; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):242-5. PubMed ID: 19367527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of linezolid-associated hematologic toxicities in a large veterans affairs medical center.
    Minson Q; Gentry CA
    Pharmacotherapy; 2010 Sep; 30(9):895-903. PubMed ID: 20795845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
    Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR
    Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
    Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic effects of linezolid in young children.
    Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia.
    Grau S; Morales-Molina JA; Mateu-de Antonio J; Marín-Casino M; Alvarez-Lerma F
    J Antimicrob Chemother; 2005 Aug; 56(2):440-1. PubMed ID: 15956097
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight.
    Niwa T; Watanabe T; Suzuki A; Ohmori T; Tsuchiya M; Suzuki T; Ohta H; Murakami N; Itoh Y
    Diagn Microbiol Infect Dis; 2014 May; 79(1):93-7. PubMed ID: 24565849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid-induced neuropathy.
    Legout L; Senneville E; Gomel JJ; Yazdanpanah Y; Mouton Y
    Clin Infect Dis; 2004 Mar; 38(5):767-8. PubMed ID: 14986270
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematologic effects of linezolid: summary of clinical experience.
    Gerson SL; Kaplan SL; Bruss JB; Le V; Arellano FM; Hafkin B; Kuter DJ
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2723-6. PubMed ID: 12121967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid-induced pancytopenia.
    Halpern M
    Clin Infect Dis; 2002 Aug; 35(3):347-8. PubMed ID: 12115109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.